Coya Therapeutics, Inc. COYA
We take great care to ensure that the data presented and summarized in this overview for Coya Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in COYA
Top Purchases
Top Sells
About COYA
Insider Transactions at COYA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 22
2023
|
Ann Lee Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+5.41%
|
$3,000
$3.62 P/Share
|
|
Jan 03
2023
|
Dov A Md Goldstein Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Anabella Villalobos Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
David S Snyder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
-
|
|
Jan 03
2023
|
Hideki Garren Director |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
-
|
|
Jan 03
2023
|
Adrian Hepner Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Conversion of derivative security
|
Direct |
6,479
+28.22%
|
$25,916
$4.0 P/Share
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Howard Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders